Why Is BRUKER CORP (BRKR) Stock Down Today?

Why BRKR stock is down today

BRKR stock fell 21.79% to $50.30 in the session, marking a sharp decline driven by a combination of earnings performance and updated guidance from Bruker Corporation. The stock's move came after the company reported second-quarter 2026 results that included a revenue miss and downwardly revised full-year revenue guidance, despite beating adjusted earnings estimates and reporting strong organic growth in its Scientific Instruments segment.

What Happened

Bruker reported Q2 2026 adjusted earnings per share of $0.49, which beat the $0.39 estimate. However, revenue came in at $838.5 million, falling short of the $853.543 million estimate. The company maintained its full-year non-GAAP EPS guidance of $2.10 to $2.15 but lowered its revenue forecast from $3.570 billion to $3.600 billion to $3.540 billion to $3.570 billion. The updated guidance reflects ongoing sector headwinds and a notable goodwill impairment charge. Bruker also announced a $20 million cost reduction initiative for FY2027 as part of its restructuring efforts. The company highlighted 10% organic growth in Scientific Instruments bookings and improved margins, but these positives were not enough to offset investor concerns over the revenue shortfall and revised sales outlook.

What The Data Shows

The stock's sharp decline occurred amid a broader market environment where the S&P 500 hit record highs and other health care stocks saw intraday and pre-market movement. Bruker’s stock is currently trading within its 52-week range of $28.53 to $65.30, with a market cap of $9.6 billion. The company remains unprofitable, with a trailing twelve-month EPS of -0.24 and a net margin of -0.3%. Recent insider transactions show three separate sales by EVP Mark Munch totaling $318,000 over the past three months, with the most recent sale occurring on July 15.

What To Watch

Investors should monitor the company’s progress on its FY2027 cost reduction plan and how it navigates ongoing sector headwinds. The next key event will be the release of Q3 2026 earnings, though no specific date is provided. Coverage breadth remains elevated, with eight stories from five sources published in the last 36 hours.